{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:38:01Z","timestamp":1790534281890,"version":"4.1.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02685","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T04:48:47Z","timestamp":1574138927000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells"],"prefix":"10.3389","volume":"10","author":[{"given":"Behnam","family":"Sadeghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Arnberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Sam\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bita","family":"Kohein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rusan","family":"Catar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Kamhieh-Milz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Geissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Moll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staffan","family":"Holmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olle","family":"Ringd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/00007890-196803000-00009","article-title":"Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues","volume":"6","author":"Friedenstein","year":"1968","journal-title":"Transplantation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2796.2007.01844.x","article-title":"Immunomodulation by mesenchymal stem cells and clinical experience","volume":"262","author":"Le Blanc","year":"2007","journal-title":"J Intern Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","article-title":"Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease","volume":"81","author":"Ringd\u00e9n","year":"2006","journal-title":"Transplantation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1097\/MIB.0000000000000441","article-title":"Human Placenta-derived Cells (PDA-001) for the treatment of moderate-to-severe Crohn's disease: a phase 1b\/2a study","volume":"21","author":"Melmed","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1586\/ern.11.113","article-title":"Harnessing the therapeutic potential of mesenchymal stem cells in multiple sclerosis","volume":"11","author":"Darlington","year":"2011","journal-title":"Expert Rev Neurother"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/scrt94","article-title":"The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms","volume":"3","author":"Morando","year":"2012","journal-title":"Stem Cell Res Ther"},{"key":"B8","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal stromal cells: clinical challenges and therapeutic opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1093\/eurheartj\/ehv136","article-title":"Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial)","volume":"36","author":"Mathiasen","year":"2015","journal-title":"Eur Heart J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13287-016-0341-0","article-title":"Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010\u20132015)","volume":"7","author":"Singh","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"B11","doi-asserted-by":"publisher","first-page":"eaam7828","DOI":"10.1126\/scitranslmed.aam7828","article-title":"Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation","volume":"9","author":"Galleu","year":"2017","journal-title":"Sci Transl Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-3-319-45457-3_7","article-title":"Cryopreserved or fresh mesenchymal stromal cells: only a matter of taste or key to unleash the full clinical potential of MSC therapy?","volume":"951","author":"Moll","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3389\/fimmu.2019.01191","article-title":"Immunomodulation by Mesenchymal Stem Cells (MSCs): mechanisms of action of living, apoptotic, dead MSCs","volume":"10","author":"Weiss","year":"2019","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3389\/fimmu.2019.01228","article-title":"The necrobiology of mesenchymal stromal cells affects therapeutic efficacy","volume":"10","author":"Weiss","year":"2019","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.molmed.2018.12.006","article-title":"Intravascular mesenchymal stromal\/stem cell therapy product diversification: time for new clinical guidelines","volume":"25","author":"Moll","year":"2019","journal-title":"Trends Mol Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1600-065X.2011.01002.x","article-title":"Gimme shelter: the immune system during pregnancy","volume":"241","author":"Munoz-Suano","year":"2011","journal-title":"Immunol Rev"},{"key":"B17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41586-018-0698-6","article-title":"Single-cell reconstruction of the early maternal-fetal interface in humans","volume":"563","author":"Vento-Tormo","year":"2018","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1089\/scd.2015.0120","article-title":"Different procoagulant activity of therapeutic mesenchymal stromal cells derived from bone marrow and placental decidua","volume":"24","author":"Moll","year":"2015","journal-title":"Stem Cells Dev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1089\/scd.2013.0079","article-title":"Decidual stromal cells promote regulatory T cells and suppress alloreactivity in a cell contact-dependent manner","volume":"22","author":"Erkers","year":"2013","journal-title":"Stem Cells Dev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1365-2249.2011.04540.x","article-title":"Stromal cells from term fetal membrane are highly suppressive in allogeneic settings in vitro","volume":"167","author":"Karlsson","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1111\/trf.12421","article-title":"Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices","volume":"54","author":"Sharma","year":"2014","journal-title":"Transfusion"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","article-title":"Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials","volume":"7","author":"Lalu","year":"2012","journal-title":"PLoS ONE"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e17850","DOI":"10.7554\/eLife.17850","article-title":"Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial","volume":"5","author":"Lalu","year":"2016","journal-title":"Elife"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3389\/fimmu.2019.01645","article-title":"Mesenchymal stromal cell therapeutic delivery: translational challenges to clinical application","volume":"10","author":"Caplan","year":"2019","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMp1613723","article-title":"Clarifying stem-cell therapy's benefits and risks","volume":"376","author":"Marks","year":"2017","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1002\/stem.2050","article-title":"Bone marrow-derived mesenchymal stem cells have innate procoagulant activity and cause microvascular obstruction following intracoronary delivery: amelioration by antithrombin therapy","volume":"33","author":"Gleeson","year":"2015","journal-title":"Stem Cells"},{"key":"B27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.7150\/thno.16911","article-title":"Heparin improves BMSC cell therapy: anticoagulant treatment by heparin improves the safety and therapeutic effect of bone marrow-derived mesenchymal stem cell cytotherapy","volume":"7","author":"Liao","year":"2017","journal-title":"Theranostics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/stem.1111","article-title":"Are therapeutic human mesenchymal stromal cells compatible with human blood?","volume":"30","author":"Moll","year":"2012","journal-title":"Stem Cells"},{"key":"B29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/sctm.17-0167","article-title":"Placenta-derived decidua stromal cells for treatment of severe acute graft-versus-host disease","volume":"7","author":"Ringden","year":"2018","journal-title":"Stem Cells Transl Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000485735","article-title":"Placenta-derived decidua stromal cells for hemorrhagic cystitis after stem cell transplantation","volume":"139","author":"Aronsson-Kurttila","year":"2018","journal-title":"Acta Haematol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/j.jcyt.2015.09.001","article-title":"Xeno-immunosuppressive properties of human decidual stromal cells in mouse models of alloreactivity in vitro and in vivo","volume":"17","author":"Sadeghi","year":"2015","journal-title":"Cytotherapy"},{"key":"B32","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3727\/096368915X688191","article-title":"Intra-arterial administration of placenta-derived decidual stromal cells to the superior mesenteric artery in the rabbit: distribution of cells, feasibility, and safety","volume":"25","author":"Arnberg","year":"2016","journal-title":"Cell Transplant"},{"key":"B33","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3389\/fimmu.2017.00795","article-title":"Safety and side effects of using placenta-derived decidual stromal cells for graft-versus-host disease and hemorrhagic cystitis","volume":"8","author":"Baygan","year":"2017","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1002\/stem.2891","article-title":"Intravenous infusion of human adipose mesenchymal stem cells modifies the host response to lipopolysaccharide in humans: a randomized, single-blind, parallel group, placebo controlled trial","volume":"36","author":"Perlee","year":"2018","journal-title":"Stem Cells"},{"key":"B35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13287-019-1391-x","article-title":"Role of tissue factor in the procoagulant and antibacterial effects of human adipose-derived mesenchymal stem cells during pneumosepsis in mice","volume":"10","author":"Perlee","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1002\/stem.1729","article-title":"Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?","volume":"32","author":"Moll","year":"2014","journal-title":"Stem Cells"},{"key":"B37","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/stem.1314","article-title":"Fetal membrane cells for treatment of steroid-refractory acute graft-versus-host disease","volume":"31","author":"Ringd\u00e9n","year":"2013","journal-title":"Stem Cells"},{"key":"B38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11307-009-0236-x","article-title":"Comparison of gene-transfer efficiency in human embryonic stem cells","volume":"12","author":"Cao","year":"2010","journal-title":"Mol Imaging Biol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/bmt.2008.261","article-title":"GVHD after chemotherapy conditioning in allogeneic transplanted mice","volume":"42","author":"Sadeghi","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/stem.1638","article-title":"Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responses","volume":"32","author":"Yin","year":"2014","journal-title":"Stem Cells"},{"key":"B41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1089\/scd.2014.0265","article-title":"Treatment of severe chronic graft-versus-host disease with decidual stromal cells and tracing with (111)indium radiolabeling","volume":"24","author":"Erkers","year":"2015","journal-title":"Stem Cells Dev"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2157-7633.1000244","article-title":"Successful reversal of acute lung injury using placenta-derived decidual stromal cells","volume":"4","author":"Ringden","year":"2014","journal-title":"J Stem Cell Res Ther"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1182\/blood-2002-06-1830","article-title":"Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates","volume":"101","author":"Devine","year":"2003","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000047856","article-title":"The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion","volume":"169","author":"Gao","year":"2001","journal-title":"Cells Tissues Organs"},{"key":"B45","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1600-0609.2012.01824.x","article-title":"Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation","volume":"89","author":"Forsl\u00f6w","year":"2012","journal-title":"Eur J Haematol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02685\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T04:48:51Z","timestamp":1574138931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02685\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,19]]},"references-count":46,"alternative-id":["10.3389\/fimmu.2019.02685"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02685","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,19]]},"article-number":"2685"}}